Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/591791


Philippines Phamaceuticals & Healthcare Report Q1 2008


Description: The Philippines Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on the Philippines pharmaceuticals and healthcare industry.

Until the ‘Cheaper Medicine Bill’ is fully approved by the legislature, we will be maintaining our forecasts for the Philippines’ US$2.61bn pharmaceutical market. The new law is expected to reduce the cost of many medicines, but lowering our projections is not planned. In fact, given that more people on low incomes will be able to afford quality healthcare products, we are more likely to upwardly revise our expectations for future sales. We are forecasting 5% year-on-year (y-o-y) growth through to 2012, when the market will have a valuation of US$4.02bn.

The Philippines has a nascent biotech sector, but there signs that expansion will occur soon. During Q407, local firm Servac Philippines has contracted Swedish company Pharmadule to build a state-of-the-art production facility. The US$120mn plant will make a vaccine for the prevention of rabies, which is a significant problem in the country. A prime indicator of the buoyant generic sector is The Generics Pharmacy, an enterprise that aims expand and extend the reach of generics to those on low incomes. Despite having only a minimal involvement with patented drugs, it is expanding rapidly. There are currently 27 outlets and the target is to have a 100 by mid-2008.

As part of its strategy to penetrate high growth markets, French firm Sanofi-Aventis generics subsidiary - Winthrop Pharmaceuticals - opened a branch in Cebu Province, the Philippines. The firm aims to provide high-quality and affordable medicines for a variety of conditions. To maximise sales, Winthrop Pharmaceuticals Philippines will liaise the government, presumably to get its products on state-assisted programmes.

According to a November 2007 poll, Filipinos are the second-happiest and most optimistic people in Asia, just behind the Indians, but ahead of the China, Thailand, Indonesia, Hong Kong, Malaysia and Singapore. This result is particularly surprising when one considers that the country has one of the lowest levels of self-purchased and company-provided medical insurance.


Contents: Executive Summary
Philippines Pharmaceutical and Healthcare Industry SWOT
Philippines Political SWOT
Philippines Economic SWOT
Philippines Business Environment SWOT
The Philippines: Business Environment Ranking
Pharmaceutical Ratings - Revised Methodology

Ratings Overview
Table: Pharmaceutical Business Environment Indicators
Weighting
Table: Weighting Of Components
Philippines - Pharmaceutical Business Environment Ranking
Table: Asia Pacific Pharmaceutical Business Environment Ratings
Limits of Potential Returns
Risks to Realisation Of Returns
The Philippines - Market Summary
Regulatory Regime
Table: Timeline of Cheaper Medicines Bill, 2007
Intellectual Property Regime
IP Shortcomings
IP Disputes
Counterfeit Drugs
Pricing and Reimbursement Regime
Parallel Trade
Corruption
International Co-operation

Industry Trends and Developments
Epidemiology
Healthcare Sector
Medical Tourism
Pharmaceutical Sector
Table Clinical Trial Considerations in Asia
Domestic Industry
Foreign Companies
Biotechnology
Traditional Medicines
Pharmaceutical Retail
Industry Forecast Sce
Overall Market Forecast
Table: Philippines’ Pharmaceuticals Market Trends
Key Growth Factors - Industry
Table: Philippines’ Health Expenditure Forecasts
Key Growth Factors - Macroeconomic
Philippines Pharmaceuticals & Healthcare Report Q1 2008
Table: Philippines - Economic Activity
Prescription Market Forecast
Table: Philippines’ Prescription Drugs Market Indicators (US$mn unless otherwise stated)
OTC Market Forecast
Table: Philippines’ OTC Drugs Market Indicators (US$mn unless otherwise stated)
Generics and Patented Market Forecast
Table: Philippines’ Generics and Patented Market Forecasts
Export/Import Forecasts
Table: Philippines’ Pharmaceuticals Exports & Imports Forecasts (US$mn)
Other Healthcare Data Forecasts
Table: Philippines Other Health Indicators
Key Risks to BMI’s Forecast Scenario
Competitive Landscape.50
Table: Leading Firms and Medicines in the Philippines, Q405

Company Monitor

Leading Multinational Manufacturers
GlaxoSmithKline Philippines
Pfizer
Novartis
Merck & Co
Sanofi-Aventis
Abbott Laboratories
Bristol-Myers Squibb
Wyeth
Eli Lilly

Indigenous Manufacturers
Unilab
Pascual Laboratories
Pacific Pharmaceuticals
MediChem Pharmaceuticals

Forecast Modelling
How We Generate Our Industry Forecasts
Pharmaceutical Industry
Sources


Companies Mentioned - GlaxoSmithKline Philippines - Pfizer - Novartis - Merck & Co - Sanofi-Aventis - Abbott Laboratories - Bristol-Myers Squibb - Wyeth - Eli Lilly - Unilab - Pascual Laboratories - Pacific Pharmaceuticals - MediChem Pharmaceuticals


Ordering: Order Online - visit http://www.researchandmarkets.com/reports/591791

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 12/02/2012 23:32:18
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
Philippines Phamaceuticals & Healthcare Report Q1 2008
Web Address:
http://www.researchandmarkets.com/reports/591791
Office Code:
OC8IHINLSNNSS

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €398.00



Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 12/02/2012 23:32:18

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)